May 19, 2022

BREAKING NEWS

ASH 2021: Dr. Jennifer Woyach with an Update on Ibrutinib vs. Chemoimmunotherapy as a Frontline Treatment for Chronic Lymphocytic Leukemia

An Immunologist Reviews CLL/SLL Patients and Their Compromised Immunity

Application of National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for CLL/SLL from the informCLL Real-World Registry

ASH 2021: Age-Related Differences in the Informational Experiences and Needs of Patients with Lymphoma: Results from the 2020 Lymphoma Coalition Global Patient Survey

Support Groups | Researchers

Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Support Groups | Researchers

Research & Clinical Trials

January 28, 2022

Dr. Saltzman: Some Good News on Response to a Third Dose of SARS-CoV-2 mMRA Vaccines in CLL/SLL Patients and Others with Blood Cancers

LLS (Leukemia and Lymphoma Society) has been doing extensive longitudinal research led by Dr. Larry Saltzman on blood cancer patients’ responses to SARS-CoV-2 vaccines.

CLL SOCIETY FAST FIND

One click to our most popular content.

QUICK LINKS

UPCOMING
EVENTS

CLL SOCIETY
SUPPORT GROUPS

LIST OF OFFICIAL
CLL DOCTORS

OFFICIAL STATEMENTS AND GUIDELINES

CLL SOCIETY
IN THE NEWS